Merck & Co., Inc. NYSE: MRK has filed 13-F forms with the SEC as an investor. Merck & Co., Inc. is itself a publicly traded company. Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. For more information on Merck & Co., Inc. stock, visit the Merck & Co., Inc. stock profile here.
Investment Activity
- Merck & Co., Inc. has $215.60 million in total holdings as of June 30, 2025.
- Merck & Co., Inc. owns shares of 13 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
- Approximately 0.01% of the portfolio was purchased this quarter.
- This quarter, Merck & Co., Inc. has purchased 12 new stocks and bought additional shares in 0 stocks.
- Merck & Co., Inc. sold shares of 0 stocks and completely divested from 0 stocks this quarter.
Largest Holdings
- ENTRADA THERAPEUTICS INC
- $11,691,241
Largest New Holdings this Quarter
- 898920103 - TUHURA BIOSCIENCES
- $31,109 Holding
Largest Purchases this Quarter
- TUHURA BIOSCIENCES
- 13,950 shares (about $31.11K)
